Baseline | 2 weeks | 3 months | P-value | |
---|---|---|---|---|
Lipid Profile | ||||
TC (mmol/l) | 4.7 ± 1.0 | 4.9 ± 1.1 | 4.8 ± 0.9 | 0.170 |
HDL cholesterol (mmol/l) | 1.4 ± 0.3 | 1.5 ± 0.3† | 1.4 ± 0.3 | 0.014 |
TG (mmol/l) | 1.4 ± 0.6 | 1.5 ± 0.7 | 1.6 ± 0.9 | 0.236 |
Disease Activity | ||||
CRP (mg/l) | 10 (4 to 14) | 3 (2.9 to 6)† | 5 (2.9 to 10)† | <0.001 |
ESR (mmhr) | 16 (9–34) | 10 (5–21)† | 17 (5–27) | 0.003 |
Fibrinogen (g/l) | 5.1 ± 1.0 | 4.2 ± .75 † | 4.3 ± .91† | <0.001 |
DAS 28 | 4.22 ± 0.94 | 2.71 ± 1.38† | 2.80 ± 1.30† | <0.001 |
HAQ | 2.1 ± 0.5 | 1.3 ± 0.9 † | 1.3 ± 0.9 † | <0.001 |
TNFα cytokine (pg/ml)* | 3.27 (0–65) | 16.2 (0–73) | 33.1 (0–68) | 0.452 |
Dyslipidaemia Risk Factors | ||||
BMI (kg/m2) | 30.2 ± 6.1 | 30.3 ± 6.1 | 30.3 ± 6.2 | 0.747 |
IPAQ (met min/wk) | 2850 ± 5451 | 2914 ± 3551 | 2503 ± 3163 | 0.625 |
Vascular Measurements | ||||
Microvascular endothelial-dependent and endothelial-independent function | ||||
ACh (%) | 319 ± 217 | 437 ± 247 † | 348 ± 209 | 0.017 |
SNP (%) | 252 ± 126 | 288 ± 150 | 261 ± 152 | 0.314 |
Macrovascular endothelial-dependent and endothelial-independent function | ||||
FMD (%) | 9.4 ± 6.9 | 12.0 ± 9.6 | 12.0 ± 8.1 | 0.214 |
GTN (%) | 22.6 ± 7.5 | 23.2 ± 7.0 | 23.8 ± 7.2 | 0.737 |